Cell Robotics Continues to Expand Distribution for Diabetes Laser.

Business Editors & High-Tech/Health/Medical Writers

ALBUQUERQUE, N.M.--(BW HealthWire)--Aug. 7, 2000

Cell Robotics International Inc. (OTC:CRII), a manufacturer and marketer of medical and scientific laser devices, today announced that it has reached distribution agreements with four additional distributors, including three U.S. and one international, for the Lasette(TM) product line.

The award-winning Lasette technology is the only U.S. FDA-approved alternative to the steel lancet for drawing capillary blood. The Personal Lasette is a miniature laser finger perforator, slightly larger than a cell phone, that allows diabetics to draw blood to test blood glucose levels with minimal pain and no residual soreness, eliminating needle phobia. Detailed information about purchasing the Lasette and media-quality photos can be found at www.cellrobotics.com.

Commenting on the hiring of the four additional distributors, Terry Hamilton, national sales director for Cell Robotics, stated: "Building strong distribution channels will make purchasing the Personal Lasette convenient and easy for the customer. This network, combined with our strong advertising efforts, will provide the necessary combination for meaningful sales growth."

The four new Lasette distributors are as follows:

Diabetic Promotions, located in Willowick, Ohio, has included the Personal Lasette on its Web site at www.diabeticpromotions.com. To date, Dave Snyder, president of Diabetic Promotions, has had more than 700 inquiries on the personal Lasette. Established in 1986, the company was one of the first distributors to offer diabetic products through e-commerce. In addition to the Web site, customers may also purchase the Lasette from the company by calling 800/433-1477.

Advantage Health Service, Willow Grove, Pa., has revenues of more than $88 million to the consumer market and more than $40 million in annual sales to the institutional/clinical market. President Joel Shpigel also heads two other companies that market to Durable Medical Equipment Providers (DMEs) and wholesale medical suppliers. Along with Advantage's Web site at www.advantagerx.com, the company may also be reached at 800/682-8283.

Jackson Medical Inc., based in Temple, Texas, and owned and managed by Pat Jackson, is a retail distributor that supplies Central Texas with general home health services and medical products, including diabetic supplies. The company can be reached at 800/234-9479.

The newly added international distributor is Jiwon Medical Co. Ltd., which is based in Korea. Jiwon was established in 1985 and specializes in the diabetes and ophthalmology markets. Daehwan Oh, president of Jiwon Medical, has been in the medical product business for more than 30 years. Jiwon Medical has developed close, long-term relationships with several hospitals, clinics and physicians offices in Korea. The company's strong sales team, which numbers 43, has a 50% market share of the recognized diabetes market in Korea.

Cell Robotics requests that international distributors interested in distributing the Lasette submit a form, which can be found at http://www.cellrobotics.com/DIS_Form.html.

Diabetes is a chronic disease that currently has no cure and is a leading cause of death worldwide. The International Diabetes Institute provides the following numbers of people with diabetes by region: 16.9 million in North America, 23.7 million in Europe, 51.2 million in Asia and 12.6 million in Latin America.

About Cell Robotics

Cell Robotics International Inc. is a medical products company committed to enhancing the quality of life through technology. CRII manufactures, markets and distributes the Lasette(TM), the only FDA-cleared alternative to the needle or steel blade lancet currently available for diabetics to draw blood so as to test their glucose levels, and the Cell Robotics Workstation, an innovative scientific research instrument that uses laser light to transform a microscope from a viewing device into a tool for physically manipulating and dissecting living cells in micro-space.

Additional information on all Cell Robotics' products is available on the company's Web site at http://www.cellrobotics.com, by e-mail at [e-mail], or by telephone at 505/343-1131.

As a cautionary note to investors, certain matters discussed in this news release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; the company's ability to execute its service and product sales plans; and the risks described from time to time in the company's Securities and Exchange Commission filings.